Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer
Authors
Keywords
Prostate cancer, Bone metastasis, Androgen-dependence, Osteosclerosis
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 33, Issue 4, Pages 325-337
Publisher
Springer Nature
Online
2016-02-12
DOI
10.1007/s10585-016-9781-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate Cancer, Version 2.2014
- (2017) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Expression of ERG protein in prostate cancer: variability and biological correlates
- (2015) G. Ayala et al. ENDOCRINE-RELATED CANCER
- Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies
- (2015) E. David Crawford et al. JOURNAL OF UROLOGY
- Animal Models of Bone Metastasis
- (2015) J. K. Simmons et al. VETERINARY PATHOLOGY
- Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype
- (2014) Matthias Saar et al. CANCER LETTERS
- CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice
- (2014) Patrick Brennecke et al. CLINICAL & EXPERIMENTAL METASTASIS
- Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib
- (2014) Timothy J. Graham et al. JNCI-Journal of the National Cancer Institute
- The role of PI3K/AKT-related PIP5K1 and the discovery of its selective inhibitor for treatment of advanced prostate cancer
- (2014) J. Semenas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vulnerabilities of PTEN-TP53-Deficient Prostate Cancers to Compound PARP-PI3K Inhibition
- (2014) E. Gonzalez-Billalabeitia et al. Cancer Discovery
- The Host Microenvironment Influences Prostate Cancer Invasion, Systemic Spread, Bone Colonization, and Osteoblastic Metastasis
- (2014) Sourik S. Ganguly et al. Frontiers in Oncology
- Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies
- (2013) Malin Hagberg Thulin et al. CLINICAL & EXPERIMENTAL METASTASIS
- Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases
- (2013) Canan Akfirat et al. JOURNAL OF PATHOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Of mice and men-warning: Intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively
- (2013) J.P. Michiel Sedelaar et al. PROSTATE
- Establishment and serial passage of cell cultures derived from LuCaP xenografts
- (2013) Sarah R. Young et al. PROSTATE
- Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases
- (2013) Sandy R. Larson et al. PROSTATE
- The sva package for removing batch effects and other unwanted variation in high-throughput experiments
- (2012) Jeffrey T. Leek et al. BIOINFORMATICS
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Advances in osteoclast biology: old findings and new insights from mouse models
- (2011) James R. Edwards et al. Nature Reviews Rheumatology
- Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
- (2011) A. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cediranib inhibits both the intraosseous growth of PDGF D-Positive prostate cancer cells and the associated bone reaction
- (2011) Abdo J. Najy et al. PROSTATE
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- Preclinical development of molecular-targeted agents for cancer
- (2010) Alberto Ocana et al. Nature Reviews Clinical Oncology
- Experimental orthotopic prostate tumor in nude mice: Techniques for local cell inoculation and three-dimensional ultrasound monitoring
- (2010) Matthias Saar et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer
- (2008) W M van Weerden et al. BRITISH JOURNAL OF CANCER
- FGF-8 is involved in bone metastasis of prostate cancer
- (2008) Maija P. Valta et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started